These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23999684)

  • 21. Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study.
    Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage C; Gunathilaka B; Jayathunge S; de Silva HJ
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):401-5. PubMed ID: 26256085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
    Afzali A; Berry K; Ioannou GN
    Liver Transpl; 2012 Jan; 18(1):29-37. PubMed ID: 21932374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
    Ayata G; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
    Hum Pathol; 2002 Nov; 33(11):1098-104. PubMed ID: 12454814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
    Wong RJ; Ahmed A
    Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.
    Nagpal SJ; Kabbany MN; Mohamad B; Lopez R; Zein NN; Alkhouri N
    Dig Dis Sci; 2016 Jul; 61(7):2102-7. PubMed ID: 26993824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation for hepatitis C virus-related cirrhosis.
    Ascher NL; Lake JR; Emond J; Roberts J
    Hepatology; 1994 Jul; 20(1 Pt 2):24S-27S. PubMed ID: 8005575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
    Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
    Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
    Piazza NA; Singal AK
    Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of liver transplantation on autonomic dysfunction in patients with end-stage liver disease.
    Carey EJ; Gautam M; Ingall T; Douglas DD
    Liver Transpl; 2008 Feb; 14(2):235-9. PubMed ID: 18236403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program.
    Nayak NC; Vasdev N; Saigal S; Soin AS
    Hum Pathol; 2010 Mar; 41(3):425-30. PubMed ID: 19954815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis.
    Heneghan MA; Zolfino T; Muiesan P; Portmann BC; Rela M; Heaton ND; O'grady JG
    Liver Transpl; 2003 Sep; 9(9):921-8. PubMed ID: 12942453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver Disease in Sri Lanka.
    Wijewantha HS
    Euroasian J Hepatogastroenterol; 2017; 7(1):78-81. PubMed ID: 29201778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor Survival After Retransplantation in NASH Cirrhosis.
    Thuluvath AJ; Chen PH; Thuluvath PJ; Kantsevoy S; Savva Y
    Transplantation; 2019 Jan; 103(1):101-108. PubMed ID: 29470354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.